Recent trendsindicate the GLP-1 market will exceed $100 billion by 2030; this is not a surprise for the health care system as discussion and use of these medications within this class has continued to soar. As the prescribing of these medications continue to increase, pharmacists in all settings must be well versed to ensure they are able to provide appropriate counseling, education, and adjustments for patients and provide clinical insight to the healthcare team.
Sarah Lothspeich, PharmD, MPH, BCPS, BCACP, (she/her) is a clinical assistant professor with the University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences. She practices as a clinical pharmacy specialist in two University of Colorado Health Family Medicine Clinics. Clinical pharmacy services at these sites primarily consist of implementing population health management initiatives and providing pharmacotherapy consultations. Dr. Lothspeich’s areas of interest include hypertension, dyslipidemia, diabetes, and population health management.
Megan Adelman, PharmD, BCPS, BCGP, CDCES, (she/her) is a family medicine pharmacy specialist at the Cleveland Clinic Akron General Center for Family Medicine. She earned her PharmD from the Northeast Ohio Medical University and completed her postgraduate year 1 pharmacy residency at the Carolinas Medical Center and a postgraduate year 2 residency in geriatrics at the Louis Stokes Cleveland VAMC. Adelman has worked to expand pharmacy services, helping to implement multiple interdisciplinary clinics.
Paris Smith, PharmD, BCACP, (she/her/hers) is an ambulatory pharmacist with Parkview Health in Fort Wayne, Indiana. She provides direct patient care for anticoagulation, diabetes, and cardiovascular risk reduction. She graduated from SIUE School of Pharmacy in Edwardsville, IL and then went to complete her PGY-1 residency with Lovell FHCC in North Chicago, IL and her PGY-2 in ambulatory care/academia with Pacific University in Hillsboro, OR. Her current practice interests include diabetes, anticoagulation, mental health, asthma and COPD.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.